Thomas Rapp
Maître de conférences, Université Paris Descartes
Design of cost-effectiveness analyses and budget impact models for both the pharmaceutical and insurance industries. Pharmacoeconomics, pharmaceutical/health outcomes research, pharmaceutical pricing, and economic analysis of the pharmaceutical industry.
Study and Design of ESOP Adoption, Employee Stock Ownership, Defined Contribution Plan, Defined Benefit Plan, Retirement Policies, Incentive Pay, Epargne salariale, Abondement, Interessement, Participation.
64 contacts2009 - 2010In charge of health economics and pharmacoeconomics studies at INSERM U558
http://thomas.rapp.free.fr/
2007 - 2009Health Services Research
Pharmacoeconomics
Budget Impact Analysis
Cost-Effectiveness Studies
Member of the International Society For Pharmacoeconomics and Outcomes Research (ISPOR)
2003 - 2007Member of the French Finance Association (AFFI)
Member (co-founder) of the Employee Stock Ownership Network (EORN)
Dissertation: The Effect of Employee Stock Ownership Plans on Employees' Savings Behaviors
2002 - 2003CEPII is France's leading institute for research on International Economics
Economic Forecasting
www.cepii.fr
